Here are five additional things to know about Zimmer Biomet’s third-quarter financial results:
1. Zimmer Biomet saw net earnings of $249.1 million, or $353.2 million on an adjusted basis.
2. During the quarter, the company announced the broad commercial launch of the Z1 Femoral Hip System for total hip arthroplasty.
3. Zimmer Biomet acquired OrthoGrid Systems Inc., a privately held medical technology company focused on artificial intelligence-driven surgical guidance systems for total hip replacement.
4. Zimmer Biomet recorded a 53.1% bottom-line gain on a sales uptick of 4%.
5. The company now expects full-year revenue growth between 3.5% and 4%, versus its previous projected range of 4% to 5%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
